Quentin Blackford to Join Align Technology Board of Directors

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediat.

Business Wire • Aug 31, 2026

Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 28, 2026

How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook

Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.

Zacks Investment Research • Aug 17, 2026

Should Investors Buy Align as Growth Meets Valuation and Demand Risks?

ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.

Zacks Investment Research • Aug 14, 2026

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK). In September 2025, Align filed a.

Business Wire • Aug 12, 2026

Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple

Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow.

Seeking Alpha • Aug 7, 2026

Align Technology: Attractively Valued But Growth Still Needs To Pick Up

Align Technology delivered record Q2 revenue and clear aligner volumes, with robust international growth offsetting North American stagnation. ALGN's strategy centers on expanding its digital dentistry platform, leveraging financing, lower-cost products, and ecosystem growth to drive recurring revenue. Valuation at $173 per share (15–16x forward earnings) is attractive for a market leader with high margins, net cash, and ongoing share buybacks.

Seeking Alpha • Jul 31, 2026

ALGN Q2 Earnings Call Highlights Digital Growth Push

ALGN highlights record clear aligner volumes, digital workflow expansion and margin gains while balancing scanner pricing pressures and long-term growth plans.

Zacks Investment Research • Jul 30, 2026

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.

Zacks Investment Research • Jul 30, 2026

Align Technology to overhaul board following engagement with Elliott

Align Technology said on Wednesday it will add three new ​independent directors to its board and launch ‌a review of its operations, following talks with activist investor Elliott Investment Management.

Reuters • Jul 29, 2026